Rad1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Rad1 monoclonal antibodies for research focused on understanding DNA damage response pathways. Rad1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rad1 is a key component of the DNA damage response pathway, playing a vital role in maintaining genomic stability. Rad1 functions in the repair of DNA double-strand breaks and is essential for cell cycle checkpoint control. The proper functioning of Rad1 is crucial for preventing mutations and ensuring accurate DNA replication, making it an important target for cancer research and therapeutic development. Rad1 monoclonal antibodies enable researchers to investigate DNA repair mechanisms and cellular responses to genotoxic stress. Understanding Rad1's role in DNA damage response can provide valuable insights into cancer development and potential treatment strategies. Rad1 research continues to reveal new aspects of genome maintenance and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of DNA repair pathways and their implications in human health.